We’re looking for an experienced policy and public affairs professional to join our highly respected health policy think-tank. Details here: https://t.co/RI5dSC6Hny
Start the new year with a fresh challenge! We're looking for a director of external comms with experience in public affairs and health/science policy. Details: https://t.co/t7wCnCmSYJ Interested? DM for an informal chat. #genomics#SciPol#healthpolicy#personalisedmedicine
In the era of AI, the value of computer modelled and simulated evidence for clinical trials is increasing, yet uncertainty remains about its regulatory acceptability. Take a look at our report on barriers and next steps. https://t.co/0AAT1mSEXR
#insilicotrials#digitalhealth#AI
Potentially huge from @GoogleDeepMind ‘..AI model which classifies missense variants… it categorised 89% of all 71 million possible missense variants as either likely pathogenic or likely benign. By contrast, only 0.1% have been confirmed by human experts.’ #genetic#disease#AI
If you don’t know what synthetic data are, or are unsure about the risks and liabilities of working with them, or are keen to explore their potential, our timely new report, commissioned by MHRA, is a must-read: https://t.co/74XU3KaHo8
Are synthetic health data ‘personal data’? Our new report (commissioned by the MHRA) delves into this question and makes recommendations for synthetic data developers, researchers, regulators and policymakers. https://t.co/rhHzwfIg6L
📣It's official: after 7 amazing years I'll be leaving my role at LML in September.
📚This means we're looking for a new Projects Co-ordinator to join the team. If you're interested in law, medicine, bioethics and public policy, this is the job for you!
https://t.co/O1DRoK3jci
The impact of climate change is emerging into health policy discussions and PHG's Chantal Babb de Villiers will be taking part in a workshop on this very subject at #eshg2023. Happening today.
#climatechange#genomics#research#health
🦾👨⚕️ Vandaag houdt Corette Ploem, bijzonder hoogleraar Recht, zorgtechnologie en geneeskunde, haar oratie over dilemma's rond zorg en technologie. #zorgtechnologie is al overal en roept en roept ook vragen op. https://t.co/OSNrRYFNkk
@LawHealthLife
@amsterdamumc
@KNMG
Dr Maxine Mackintosh @GenomicsEngland will present our next hybrid Bradford Hill Seminar on:
'Tackling Bias and Inequities in Health and Genomic Data'
🗓️31st May, 1pm (UK)
Free registration: https://t.co/TlarWnbqKM
#Genomics#genomicdata#DataScience
We’re back! 🎉
Today we are thrilled to be launching an exciting new phase of Understanding Patient Data (UPD).
👋Meet the team and learn more about our plans for the future here:
https://t.co/o7HBm3iTqi
Very proud and delighted to share that @RDMOxford @LizOrmondroyd and I have had our work published online today. You can read our systematic review in Clinical Genetics open access here:
https://t.co/pbjIK7NOCV
#GCchat
NEW PAPER📢
When should humans remain in the loop? What are the ethical and legal considerations for automating clinical pathways? Take a look at our paper on artificial intelligence for Oesophageal Cancer. #Deltaproject#AIandhealthcare@PHGFoundation
https://t.co/jetr3GuUey
“Once you miss the opportunity to shape emerging technologies the horse has bolted. Engaging with organisations early helps ensure data protections are built in” says John Edwards on dealing with new technologies.
For those interested in 🇬🇧 #data protection reform, progressing the #DPDIBill remains top of the priority list of legislative reforms led by the new Department for Science, Innovation & Technology. Things may not happen super-fast, but will definitely happen.